atements for purposes of the safe harbor provisions under
The Private Securities Litigation Reform Act of 1995. Any statements set
forth above that are not historical facts are forward-looking statements
that involve risks and uncertainties that could cause actual results to
differ materially from those in the forward-looking statements, which may
include, but are not limited to, such factors as unanticipated changes in
product demand, increased competition, failure to obtain or maintain
intellectual property protection, downturns in the Chinese economy,
uncompetitive levels of research and development, failure to obtain
regulatory approvals, and other information detailed from time to time in
the Company's filings and future filings with the United States Securities
and Exchange Commission. The forward-looking statements made herein speak
only as of the date of this press release and the Company undertakes no
duty to update any forward-looking statement to conform the statement to
actual results or changes in the company's expectations.
CHINA PHARMA HOLDINGS, INC.
CONSOLIDATED BALANCE SHEETS
December 31, December 31,
2007 2006
ASSETS
Current Assets:
Cash and cash equivalents $ 1,830,335 $ 656,441
Trade accounts receivable, less
allowance for doubtful
accounts of $2,440,852 and
$1,562,494, respectively 18,572,976 12,101,979
Other receivables, less allowance
for doubtful accounts of
$43,908 and $27,517,
respectively 496,313 355,554
Deferred offering costs -- 59,390
Advances to suppliers 3,481,948 2,255,877
Inventory
'/>"/>
SOURCE China Pharma Holdings, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 Related biology technology :1.
China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results2.
China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results3.
China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day4.
China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.5.
China Technology Announces New Chief Financial Officer6.
China Medical Technologies Reports First Quarter Financial Results7.
China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference8.
China Technology Announces Entry to the Solar Energy Sector9.
China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products10.
Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association11.
China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch